MAVS Self-association Mediates Antiviral Innate Immune Signaling

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 2009 Feb 6

PMID 19193783

Citations 71

Authors

Eric D Tang

Cun-Yu Wang

Affiliations

Soon will be listed here.

Abstract

The innate immune system recognizes nucleic acids during viral infection and stimulates cellular antiviral responses. Intracellular detection of RNA virus infection is mediated by the RNA helicases RIG-I (retinoic acid inducible gene I) and MDA-5, which recognize viral RNA and signal through the adaptor molecule MAVS (mitochondrial antiviral signaling) to stimulate the phosphorylation and activation of the transcription factors IRF3 (interferon regulatory factor 3) and IRF7. Once activated, IRF3 and IRF7 turn on the expression of type I interferons, such as beta interferon. Interestingly, unlike other signaling molecules identified in this pathway, MAVS contains a C-terminal transmembrane (TM) domain that is essential for both type I interferon induction and localization of MAVS to the mitochondrial outer membrane. However, the role the MAVS TM domain plays in signaling remains unclear. Here we report the identification of a function for the TM domain in mediating MAVS self-association. The activation of RIG-I/MDA-5 leads to the TM-dependent dimerization of the MAVS N-terminal caspase recruitment domain, thereby providing an interface for direct binding to and activation of the downstream effector TRAF3 (tumor necrosis factor receptor-associated factor 3). Our results reveal a role for MAVS self-association in antiviral innate immunity signaling and provide a molecular mechanism for downstream signal transduction.

Citing Articles

Usutu virus NS4A suppresses the host interferon response by disrupting MAVS signaling.

Nelemans T, Tas A, Kikkert M, van Hemert M Virus Res. 2024; 347:199431.

PMID: 38969013 PMC: 11292556. DOI: 10.1016/j.virusres.2024.199431.

Mitochondrial antiviral signaling protein: a potential therapeutic target in renal disease.

Wu M, Pei Z, Long G, Chen H, Jia Z, Xia W Front Immunol. 2023; 14:1266461.

PMID: 37901251 PMC: 10602740. DOI: 10.3389/fimmu.2023.1266461.

Seneca Valley virus 3C antagonizes host innate immune responses and programmed cell death.

Zhang X, Li Y, Huang H, Zhao C, Lei X, Zhao B Front Microbiol. 2023; 14:1235620.

PMID: 37869659 PMC: 10588452. DOI: 10.3389/fmicb.2023.1235620.

Regulation of IFNβ expression: focusing on the role of its promoter and transcription regulators.

Fan J, Li Q, Liang J, Chen Z, Chen L, Lai J Front Microbiol. 2023; 14:1158777.

PMID: 37396372 PMC: 10309559. DOI: 10.3389/fmicb.2023.1158777.

Surgical Strikes on Host Defenses: Role of the Viral Protease Activity in Innate Immune Antagonism.

Chin C, Saeed M Pathogens. 2022; 11(5).

PMID: 35631043 PMC: 9145062. DOI: 10.3390/pathogens11050522.

References

Lemmon M, Flanagan J, Treutlein H, Zhang J, Engelman D . Sequence specificity in the dimerization of transmembrane alpha-helices. Biochemistry. 1992; 31(51):12719-25. DOI: 10.1021/bi00166a002. View

Zhong B, Yang Y, Li S, Wang Y, Li Y, Diao F . The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity. 2008; 29(4):538-50. DOI: 10.1016/j.immuni.2008.09.003. View

Sulistijo E, Jaszewski T, MacKenzie K . Sequence-specific dimerization of the transmembrane domain of the "BH3-only" protein BNIP3 in membranes and detergent. J Biol Chem. 2003; 278(51):51950-6. DOI: 10.1074/jbc.M308429200. View

Seth R, Sun L, Ea C, Chen Z . Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell. 2005; 122(5):669-82. DOI: 10.1016/j.cell.2005.08.012. View

Chin C, Sachs J, Engelman D . Transmembrane homodimerization of receptor-like protein tyrosine phosphatases. FEBS Lett. 2005; 579(17):3855-8. DOI: 10.1016/j.febslet.2005.05.071. View

Hiscott J, Lin R, Nakhaei P, Paz S . MasterCARD: a priceless link to innate immunity. Trends Mol Med. 2006; 12(2):53-6. DOI: 10.1016/j.molmed.2005.12.003. View

Akira S, Uematsu S, Takeuchi O . Pathogen recognition and innate immunity. Cell. 2006; 124(4):783-801. DOI: 10.1016/j.cell.2006.02.015. View

Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H . IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol. 2005; 6(10):981-8. DOI: 10.1038/ni1243. View

Clement J, Bibeau-Poirier A, Gravel S, Grandvaux N, Bonneil E, Thibault P . Phosphorylation of IRF-3 on Ser 339 generates a hyperactive form of IRF-3 through regulation of dimerization and CBP association. J Virol. 2008; 82(8):3984-96. PMC: 2292984. DOI: 10.1128/JVI.02526-07. View

10.

Sun Q, Sun L, Liu H, Chen X, Seth R, Forman J . The specific and essential role of MAVS in antiviral innate immune responses. Immunity. 2006; 24(5):633-42. DOI: 10.1016/j.immuni.2006.04.004. View

11.

Kumar H, Kawai T, Kato H, Sato S, Takahashi K, Coban C . Essential role of IPS-1 in innate immune responses against RNA viruses. J Exp Med. 2006; 203(7):1795-803. PMC: 2118350. DOI: 10.1084/jem.20060792. View

12.

Hiscott J . Convergence of the NF-kappaB and IRF pathways in the regulation of the innate antiviral response. Cytokine Growth Factor Rev. 2007; 18(5-6):483-90. DOI: 10.1016/j.cytogfr.2007.06.002. View

13.

Choi S, Lee E, Kwon S, Park H, Yi J, Kim S . Transmembrane domain-induced oligomerization is crucial for the functions of syndecan-2 and syndecan-4. J Biol Chem. 2005; 280(52):42573-9. DOI: 10.1074/jbc.M509238200. View

14.

Gitlin L, Barchet W, Gilfillan S, Cella M, Beutler B, Flavell R . Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci U S A. 2006; 103(22):8459-64. PMC: 1464000. DOI: 10.1073/pnas.0603082103. View

15.

Servant M, Grandvaux N, tenOever B, Duguay D, Lin R, Hiscott J . Identification of the minimal phosphoacceptor site required for in vivo activation of interferon regulatory factor 3 in response to virus and double-stranded RNA. J Biol Chem. 2003; 278(11):9441-7. DOI: 10.1074/jbc.M209851200. View

16.

Li R, Gorelik R, Nanda V, Law P, Lear J, DeGrado W . Dimerization of the transmembrane domain of Integrin alphaIIb subunit in cell membranes. J Biol Chem. 2004; 279(25):26666-73. DOI: 10.1074/jbc.M314168200. View

17.

Oganesyan G, Saha S, Guo B, He J, Shahangian A, Zarnegar B . Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature. 2005; 439(7073):208-11. DOI: 10.1038/nature04374. View

18.

Saito T, Hirai R, Loo Y, Owen D, Johnson C, Sinha S . Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc Natl Acad Sci U S A. 2006; 104(2):582-7. PMC: 1766428. DOI: 10.1073/pnas.0606699104. View

19.

Kayagaki N, Phung Q, Chan S, Chaudhari R, Quan C, ORourke K . DUBA: a deubiquitinase that regulates type I interferon production. Science. 2007; 318(5856):1628-32. DOI: 10.1126/science.1145918. View

20.

Saha S, Pietras E, He J, Kang J, Liu S, Oganesyan G . Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif. EMBO J. 2006; 25(14):3257-63. PMC: 1523175. DOI: 10.1038/sj.emboj.7601220. View